HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activating receptor KIR2DS2 bound to HLA-C1 reveals the novel recognition features of activating receptor.

Abstract
Killer cell immunoglobulin-like receptors (KIRs) are important receptors for regulating the killing of virus-infected or cancer cells of natural killer (NK) cells. KIR2DS2 can recognize peptides derived from hepatitis C virus (HCV) or global flaviviruses (such as dengue and Zika) presented by HLA-C*0102 to activate NK cells, and has shown promising results when used for cancer immunotherapy. Here, we present the complex structure of KIR2DS2 with HLA-C*0102 at a resolution of 2·5Å. Our structure reveals that KIR2DS2 can bind with HLA-C*0102 and HLA-A*1101 in two different directions. Moreover, Tyr45 (in activating receptor KIR2DS2) and Phe45 (in inhibitory KIRs) distinguish the two different binding models and binding affinity between activating KIRs and inhibitory KIRs. The conserved 'AT' motif of the peptide mediates recognition and determines the peptide specificity of recognition. These structural characteristics shed light on how KIRs activate NK cells and can provide a molecular basis for immunotherapy by NK cells.
AuthorsYi Yang, Hua Bai, Yankang Wu, Peng Chen, Jin Zhou, Jun Lei, Xiang Ye, Alex J Brown, Xi Zhou, Ting Shu, Yongshun Chen, Pengcheng Wei, Lei Yin
JournalImmunology (Immunology) Vol. 165 Issue 3 Pg. 341-354 (03 2022) ISSN: 1365-2567 [Electronic] England
PMID34967442 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 John Wiley & Sons Ltd.
Chemical References
  • HLA-C Antigens
  • KIR2DS2 protein, human
  • Peptides
  • Receptors, KIR
Topics
  • HLA-C Antigens
  • Hepacivirus (metabolism)
  • Humans
  • Killer Cells, Natural
  • Peptides (metabolism)
  • Receptors, KIR (metabolism)
  • Zika Virus
  • Zika Virus Infection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: